Today, Bioinformatics Solutions Inc. (BSI) will be releasing PEAKS X within its PEAKS Studio platform, to provide a complete and vendor neutral solution for DDA and DIA discovery proteomics. The latest features added to the software include: • Resolution for Chimeric Spectra • Spectral-Library-Free DIA Support • De Novo Sequencing for DIA Data • Improved […]
Boulder, Colo. – Inscripta™, a leading gene-editing technology company, today announced the addition of Jason T. Gammack as the company’s first chief commercial officer. Gammack, a 25-year veteran of life sciences commercial operations, will leverage his experience at leading biotechnology companies to design and oversee Inscripta’s sales, marketing, business development, and customer support operations. “We are […]
With the goal of developing a novel immunotherapy for patients with glioblastoma, the research grant winner will employ xCELLigence Real Time Cell Analysis technology to develop armored CAR-T cells XCELLIGENCE IMMUNOTHERAPY RESEARCH GRANT WINNER DR. BRYAN CHOI IS A POSTDOCTORAL FELLOW WITH DR. MARCELA V. MAUS IN THE MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER AND […]
Precipio ICE COLD-PCR™ reagents will be sold with PerkinElmer DNA/RNA extraction and isolation products NEW HAVEN, CT – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced an agreement with PerkinElmer to jointly offer Precipio’s ICE COLD-PCR (ICP) mutation enrichment technology together with PerkinElmer’s NextPrep-Mag™ cell-free DNA isolation kit, Janus® G3 liquid handling workstation, and chemagic™ MSM […]
Specialized CRO offers high-definition tissue imaging services for pharmaceutical and clinical research SOUTH SAN FRANCISCO, Calif. and PORTLAND, Ore. — Sirona Dx, a leader in high-complexity genomics and proteomics services, today announced the introduction of Imaging Mass Cytometry™ services on the Fluidigm Hyperion™ Imaging System to advance biomarker discovery and therapeutic development. Sirona Dx is a specialized […]
First commercially available reference standard for microsatellite instability (MSI) testing Horizon Discovery’s reference material covers seven new MSI markers tested for on the Idylla™ platform MSI is a form of genetic instability that is predominantly found in colorectal, gastric and endometrial cancer and serves as a prognostic, diagnostic and predictive marker in the clinic Cambridge, […]
The Olympus high-sensitivity SpinSR10 super resolution microscope combines fast 0.005 seconds/frame acquisition speed and 120-nanometer super resolution with improvements that provide clearer images and three times the brightness of the standard SpinSR10 model. Super resolution microscopes are used in medical and biological research to observe the internal structure of cells in fine detail, and brightness […]
San Diego, CA – Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the Chimeric ID Panel designed to reduce the time and cost of performing chimerism analysis for bone marrow engraftment monitoring studies. The SNP-based panel is designed for research use with the MassARRAY® system and is accompanied by software […]
Dublin, Ireland, and Cambridge, UK – ERS Genomics Limited and DefiniGEN Ltd announced today a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents. DefiniGEN will combine their best-in-class iPSC (induced Pluripotent Stem Cell) differentiation platform with CRISPR/Cas9 technology to generate a range of innovative preclinical human models. “The company’s […]
Los Angeles, CA – Calibre Scientific is pleased to announce that it has completed the acquisition of Kalon Biological Limited and Clin-Tech Limited (together “KalonBio“ or the “Company”). The Company specializes in the development and manufacture of a range of medical diagnostic kits, commercial ELISA (enzyme immunoassays [EIA]) kits and reagents for the healthcare and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
